What is the Lansky Play-Performance Scale?

The Lansky Play-Performance Scale is a clinician- and caregiver-oriented tool that describes pediatric functional status through the lens of play and activity. Unlike scales built around adult work roles or self-care tasks, Lansky anchors function to behaviors that are developmentally meaningful for children: running and active games, school participation, quiet play, time out of bed, and basic interaction with the environment.

Scores are reported on an ordinal scale from 100 to 0 in steps of 10. Higher scores indicate more typical, energetic participation in age-appropriate play; lower scores indicate progressive restriction, bed rest, reduced interaction, and—at the extreme—minimal responsiveness. The scale is intentionally global: it integrates the net effect of disease burden, symptoms (such as pain, fatigue, dyspnea, nausea), anemia, infection, neurologic impairment, and treatment toxicity into a single summary that teams can track over time.

Why play is used as the functional anchor

In pediatrics, play is a primary “job” of childhood. It reflects cardiorespiratory reserve, musculoskeletal strength, mood, cognition, and the child’s capacity to engage socially. When a serious illness or intensive therapy disrupts play, families often notice changes before formal performance testing or laboratory trends fully explain what is happening. For that reason, Lansky has strong face validity for parents and can support shared understanding during clinic visits, hospital rounds, and home-care planning.

Because the scale is global, it should be interpreted as a summary measure, not a substitute for a detailed history, examination, disease-specific staging, or objective tests. Its strength is longitudinal tracking and communication; its weakness is that it cannot, by itself, identify the specific driver of functional decline.

Relationship to the Karnofsky Performance Status Scale

Clinicians often describe Lansky as the pediatric analogue of the Karnofsky Performance Status (KPS) scale used in adults. Both instruments use a 100-point framework descending in tens, and many oncology workflows treat the numeric level as a parallel reporting convention when comparing pediatric and adult datasets or trial strata.

However, the content of the anchors differs materially. Karnofsky emphasizes employment, housework, and self-care in an adult social context. Lansky emphasizes play patterns, stamina, and caregiver observation of activity. Numeric parity (for example, “Lansky 70” and “KPS 70”) can be useful for administrative reporting, but it should not be mistaken for strict biological or prognostic equivalence across ages.

A critical safety note for documentation: Lansky 0 describes “unresponsive,” not death. Karnofsky 0 explicitly encodes death in many oncology conventions. Teams should avoid copying adult KPS habits onto pediatric charts without noting this difference, especially when building order sets, flowsheets, or automated alerts.

Who typically provides the information?

In routine pediatric oncology practice, Lansky is commonly informed by parent or primary caregiver report, supplemented by nursing and physician observation. Some protocols specify who should assign the score, the look-back interval, and whether the score reflects “usual” status versus the child’s “best” day in a cycle. Consistency matters: mixing anchors (for example, comparing a score based on “the past week” with a later score based on “today only”) can create artifactual swings that look like clinical change.

Developmental stage also shapes how a given score “looks” in real life. A teenager’s “active play” differs from a toddler’s, and school attendance may be a major functional signal for school-aged children. Experienced clinicians often triangulate Lansky with school performance, sleep, oral intake, pain control, and mobility aids when interpreting a borderline category.

Standard score definitions (100 to 0)

The table below summarizes the commonly published Lansky descriptors used in pediatric oncology references. Wording can vary slightly by institution or trial document; when a protocol provides explicit definitions, the protocol should take precedence.

How clinicians use Lansky in practice

Serial monitoring through therapy

Many teams record Lansky at baseline and at defined time points during chemotherapy, radiation, immunotherapy, or surgical recovery. A sustained drop may prompt evaluation for reversible contributors such as fever and infection, anemia, dehydration, electrolyte disturbance, inadequate analgesia, sleep disruption, or medication adverse effects, in addition to progression of disease.

Treatment intensity and supportive care planning

Lower Lansky scores often correlate with reduced tolerance of aggressive therapy in real-world cohorts, although decisions must always be individualized. The scale can help structure conversations about dose modifications, inpatient versus outpatient management, nutrition support, physical and occupational therapy, school accommodations, and family caregiving resources.

Clinical trials and registry reporting

Pediatric oncology trials may use Lansky for eligibility, stratification, or toxicity-related functional endpoints. When Lansky is trial-defined, follow the case report form instructions for timing, reporter, and handling of hospitalization or sedation. Off-protocol use may still be clinically valuable, but it may not satisfy regulatory or auditing expectations unless aligned with source documentation standards.

Interpretation: what Lansky does and does not measure

Lansky is best understood as a global functional thermometer. It does not quantify pain intensity, specific neurologic deficits, pulmonary function, cardiac output, or nutritional status. It can remain misleadingly stable if a child is “pushing through” symptoms, or appear worse if a family is appropriately cautious after a recent complication. Cultural expectations around rest, school attendance, and physical activity also influence reporting.

Inter-rater differences between parents and clinicians are common. Rather than treating disagreement as an error, teams often use discordance as a signal to explore unmet needs: fear of injury, undervalued symptoms, home environment constraints, or differing definitions of “usual” play.

Limitations and prudent use

• Subjectivity and anchor dependence: Scores reflect judgment and the chosen time window; they are not objective laboratory measurements.
• Developmental heterogeneity: The same numeric label may correspond to different real-world function at different ages.
• Not a stand-alone safety tool: A child may have serious physiologic risk despite a relatively preserved Lansky score, especially early in illness or with compensated chronic conditions.
• Zero score semantics: Lansky 0 indicates profound unresponsiveness in the scale’s framing; it is not interchangeable with adult “KPS 0” conventions without explicit local definition.
• Complement, don’t replace, comprehensive assessment: Integrate Lansky with exam findings, disease-specific staging, imaging, labs, patient-reported outcomes, and family goals.

Using this calculator on CalcMD

The companion calculator helps teams quickly retrieve the canonical descriptor for a selected Lansky level and provides brief contextual notes about typical clinical implications and the Karnofsky numeric parallel used in many oncology workflows. It is an educational aid and should be applied alongside institutional pathways, active clinical judgment, and—when applicable—trial-specific rules.